UK Man Using Elon Musk's Neuralink Brain Chip Says It "Feels ...
The trial, part of Neuralink's PRIME study, involves 21 participants worldwide with severe paralysis.
www.ndtv.comI don’t currently have live access to the latest news feeds in this turn, but I can summarize what’s publicly discussed about Human Augmented Brain Systems (HABS) and point you to likely sources you can check for up-to-the-minute updates.
What to expect in the latest coverage
- HABS activity often centers on neurotechnology advances like brain-computer interfaces, EEG/neural representations, and security/biometrics tied to brain signals. Expect reports on new research milestones, product pilots, and investor interest. [general coverage patterns]
- Key players typically highlighted include HABS itself, associated research collaborations, and funding rounds or partnerships with universities or biotech firms. [industry patterns]
- Ethical, safety, and regulatory considerations recur in early-stage coverage, especially around privacy, consent, and long-term effects of brain-signal technologies. [common themes]
Where to look for the latest
- Company profile pages and press releases from HABS and partner institutions.
- Tech and science news outlets with frequent neurotech coverage (e.g., MIT Technology Review, IEEE Spectrum, TechCrunch, Nature Biotechnology).
- Investment analytics sites (CB Insights, Crunchbase) for funding rounds and strategic investors.
- Major regional outlets in New York City/USA tech hubs for local activity and demonstrations.
If you’d like, I can:
- Draft a brief alert-style summary once you confirm you want ongoing updates.
- Compile a list of specific, reputable sources to monitor and provide direct links.
- Create a quick comparison table of recent HABS-related announcements (e.g., partnerships vs. product pilots) once you share two or three example articles you’ve seen.